133 related articles for article (PubMed ID: 16974192)
1. Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
Rettenbacher MA; Baumgartner S; Eder-Ischia U; Edlinger M; Graziadei I; Hofer A; Huber R; Hummer M; Kemmler G; Weiss E; Fleischhacker WW
J Clin Psychopharmacol; 2006 Oct; 26(5):500-3. PubMed ID: 16974192
[TBL] [Abstract][Full Text] [Related]
2. Risperidone and liver function tests in children and adolescents: a short-term prospective study.
Erdogan A; Atasoy N; Akkurt H; Ozturk D; Karaahmet E; Yalug I; Yalug K; Ankarali H; Balcioglu I
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):849-57. PubMed ID: 18258348
[TBL] [Abstract][Full Text] [Related]
3. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
4. Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain.
Himmerich H; Kaufmann C; Schuld A; Pollmächer T
J Psychiatr Res; 2005 Jan; 39(1):35-42. PubMed ID: 15504422
[TBL] [Abstract][Full Text] [Related]
5. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
6. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
7. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
[TBL] [Abstract][Full Text] [Related]
8. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
9. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
10. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.
Papatheodoridis GV; Goulis J; Christodoulou D; Manolakopoulos S; Raptopoulou M; Andrioti E; Alexandropoulos N; Savvidou S; Papachristou A; Zervou E; Seferiadis K; Kousidou P; Vogiatzakis E; Tsianos E
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):281-7. PubMed ID: 17353691
[TBL] [Abstract][Full Text] [Related]
12. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
13. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
Elsebae MM; Abu-Zekri NB
Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
[TBL] [Abstract][Full Text] [Related]
14. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
[TBL] [Abstract][Full Text] [Related]
15. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
Huang TL; Lu CY
Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
[TBL] [Abstract][Full Text] [Related]
16. [Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain].
Shao P; Zhao JP; Chen JD; Wu RR; He YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):312-5. PubMed ID: 18460774
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia, obesity, and antipsychotic medications: what can we do?
Citrome L; Vreeland B
Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
[TBL] [Abstract][Full Text] [Related]
18. Weight gain and first-generation antipsychotics: experience from a developing country.
Yoon CK
J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
[No Abstract] [Full Text] [Related]
19. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
Hrdlicka M; Zedkova I; Blatny M; Urbanek T
Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
Rege S
Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]